{"id":"W2328501245","doi":"10.1097/igc.0b013e31826d1438","title":"Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile","year":2012,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Topotecan; Medicine; Lapatinib; Internal medicine; Oncology; Gefitinib; Epidermal growth factor receptor; Cancer; Chemotherapy; Pharmacology; Trastuzumab; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003726053,0.0005496832,0.001366219,0.0006660526,0.0001968247,0.000688885,0.0003816359,0.0006055098,0.00332089],"category_scores_gemma":[0.008288031,0.0002199165,0.003079704,0.0004723591,0.0003608547,0.0007702906,0.000447935,0.00100396,0.0004814583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001038705,"about_ca_system_score_gemma":0.0005466641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001151948,"about_ca_topic_score_gemma":0.004334001,"domain_scores_codex":[0.9986117,0.0005760181,0.0001571684,0.0001399704,0.0002156388,0.0002995322],"domain_scores_gemma":[0.9934263,0.004546972,0.0007071178,0.0001724533,0.0002645185,0.000882611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.3096515,0.001850709,0.3228908,0.001568097,0.01234879,0.002119297,0.0001159819,0.02692101,0.01670589,0.001621463,0.002190496,0.302016],"study_design_scores_gemma":[0.008035885,0.05287675,0.8930339,0.0001928237,0.01753736,0.002710539,0.0002444945,0.01224617,0.005197552,0.003860899,0.003958364,0.0001052531],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633319,0.01984508,0.002775466,0.00202438,0.0002265896,0.0002323097,0.002401836,0.00005830339,0.009104126],"genre_scores_gemma":[0.9948912,0.001662038,0.0008315476,0.0005032411,0.000189396,0.00006473829,0.001021649,0.00001079947,0.0008253141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003726053,"threshold_uncertainty_score":0.01970547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09748817472018313,"score_gpt":0.4124924580605192,"score_spread":0.315004283340336,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}